Brief: BB Biotech Q2 Net Loss At CHF 13 Mln

Bb Biotech

21/07/2023 06:04

July 21 (Reuters) - BB BIOTECH AG  BION.S :
    * SECTOR ROTATION AND FUND OUTFLOWS WEIGH ON BIOTECH STOCKS,
BUT
POSITIVE DEVELOPMENTS ALLOW FUND RAISING TO STRENGTHEN INDUSTRY
    * Q2 NET LOSS OF CHF 13 MN
    * NET LOSS OF CHF 267 MN FOR FIRST HALF OF 2023 COMPARED TO
A NET
LOSS OF CHF 533 MN IN SAME PERIOD LAST YEAR
    * Q2 INVESTMENT LEVEL OF 113.7%, CLOSE TO 114% AT END OF Q1
AND
113.6% AT END OF 2022

Source text for Eikon:  ID:nEQ42HVQra 
Further company coverage:  BION.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))